Even though Covid may not be as strong as it used to be, people are still afraid because of a new sub-variant in India. The rapid growth of the new variant of COVID-19 has caused concern, and the government has told states to be ready for possible problems.
Understanding COVID-19 variant JN.1
So there is a new variant on the COVID-19 block, BA.2.86 as well known as Pirola. Scientists are keeping a close eye on it because its spike protein has mutated in a number of ways. This protein is what the virus uses to get into our cells. It is also the spike protein that our immune systems use to find the virus.
According to virologist Jesse Bloom the mutations in the spike protein of the BA.2.86 variant are like a big leap in the evolution of the virus, similar to the difference between the original coronavirus and the first Omicron variant. This makes it important for scientists to closely monitor and study this new variant.
Earlier the data suggested that the new vaccines would be as effective against BA.2.86, but instead, it created some antibodies against it and it doesn’t spread as quickly as other variants.
BA.2.86 did not turn out to be as frightening as expected; instead, it mutated into the most recent form, JN.1, which is rapidly spreading. The JN.1 virus is a new type of the Omicron subvariant BA.2.86, which is also called Pirola and is part of SARS-CoV-2. It has an extra change in its spike protein. The version can spread quickly and get past immune systems, which shows that the situation in India needs to be closely watched and handled with care.
An early November investigation discovered that JN.1 had a mutation that allowed it to hide from the immune system. Vaccines and recent infections reduce JN.1 risk, although not entirely.
Also Read:
COVID 19 variant JN.1 symptoms
As compared, JN.1 is identical to the other variants of the COVID-19 virus. The new COVID-19 symptoms are fever, runny nose, sore throat, headache, and minor gastrointestinal symptoms such as abdominal pain and diarrhoea, which are similar to those caused by previous strains of the virus. The symptoms include fever, congestion, and headache.
Even though there are worries about how easily it can be passed on, the Centers for Disease Control and Prevention (CDC) say there is no proof that JN.1 is more dangerous than other variants that are spreading.
The CDC also says that JN.1 may be better at getting past our immune systems, but that doesn’t mean it causes more serious illnesses or more trips to the hospital. In most cases, symptoms get better in four to five days. Some of the patients may also have trouble breathing.
Current Scenario of COVID Variant-Deadly or not?
As WHO proclaimed the current virus JN.1 doesn’t pose risk as expected. Based on the current evidence the virus has very low health treatment.
According to virologist Dr. Jacob John, as stated in TOI, all Omicron sub-variants, including JN.1, are less pathogenic. He stresses that vulnerable people over the age of 70 with comorbidities are at a higher risk of developing severe COVID.
To protect yourself, avoid crowds, and wear masks when traveling or in public places. If a younger family member has a fever, they should keep a safe distance and wear masks around high-risk persons, including at home. Keeping good hand hygiene is crucial for overall safety.